Hosted on MSN22h
Oppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worries
Apple is having it hard. Oppenheimer downgraded it from “outperform” to “perform” amidst weak sales. The reason behind this ...
Apple Gets Another Downgrade on iPhone Risk Ahead of Results
Apple Inc. was downgraded to perform from outperform at Oppenheimer, in the latest sign of caution building ahead of the ...
Apple (AAPL) Gets Downgraded on Reduced iPhone Sales Estimates
Investment firm Oppenheimer has downgraded tech giant Apple (AAPL) stock from Buy to Hold due to reduced estimates for iPhone ...
Apple earnings: What to expect on iPhone sales, AI as stock looks to reignite
Apple reports fiscal first-quarter earnings after the close of trading Thursday. Analysts will be focused on iPhone momentum ...
Apple Downgraded by Oppenheimer as iPhone Sales Slow, China Market Shrinks
Apple's falling market share in China is a major concern: iPhone shipments in Q4 dropped 25%, and the full year 2024 fell 17% ...
Oppenheimer downgrades Apple to Perform on slower replacement, China share loss
Oppenheimer analyst Martin Yang downgraded Apple (AAPL) to Perform from Outperform with no price target as the firm lowered its FY26 EPS ...
Apple to report Q1 earnings a week after stock hit with multiple downgrades
According to estimates by IDC and Canalys, overall iPhone market share fell 1% year over year in Q4 to 23% despite the ...
Is Apple Intelligence getting the job done?
Investors were hoping that Apple Intelligence would drive a wave of iPhone upgrades. How's that playing out? This will be the first full quarter of results from Apple since the company's iPhone 16 ...
Apple downgraded, Rivian initiated: Wall Street's top analyst calls
Baird downgraded Leap Therapeutics (LPTX) to Neutral from Outperform with a price target of $1.25, down from $9, after the ...